0001645113-22-000023.txt : 20220307 0001645113-22-000023.hdr.sgml : 20220307 20220307182825 ACCESSION NUMBER: 0001645113-22-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220303 FILED AS OF DATE: 20220307 DATE AS OF CHANGE: 20220307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longsworth Todd Christopher CENTRAL INDEX KEY: 0001693530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 22719724 MAIL ADDRESS: STREET 1: NOVOCURE, 20 VALLEY STREAM PARKWAY STREET 2: SUITE 300 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_164669568882280.xml FORM 4 X0306 4 2022-03-03 0 0001645113 NovoCure Ltd NVCR 0001693530 Longsworth Todd Christopher C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 General Counsel Ordinary Shares 2022-03-03 4 S 0 1094 74.498 D 66774 D Ordinary Shares 2022-03-04 4 S 0 1973 70.407 D 64801 D Options to Buy Ordinary Shares 80.59 2022-03-03 4 A 0 6106 80.59 A 2023-03-01 2032-02-29 Ordinary Shares 6106.0 6106 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Options to buy 6,106 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates. By: /s/ Steven Robbins, Attorney in Fact for Todd Longsworth 2022-03-07